Evaluate

April 11, 2017

First-quarter deal making shows glimmers of growth

2017 deal making opens with a bang, though transaction volume remains low.

February 27, 2017

Therapy focus – against the odds, cancer vaccines plough on

January 10, 2017

JP Morgan – Valeant finds a way to make Dendreon profitable